Sixth Consecutive Quarter of Year-Over-Year Volume Growth
Despite volatile macroeconomic conditions, Dow delivered its sixth consecutive quarter of year-over-year volume growth.
Cost Reduction Initiatives
Dow announced at least $1 billion in annualized cost reductions by 2026, including eliminating 1,500 roles and delaying construction at the Alberta project to align with market recovery.
Strategic Infrastructure Transaction
The strategic transaction with Macquarie Asset Management for a minority stake is expected to generate $2.4 billion in initial cash proceeds, with the potential for an additional $600 million.
Regulatory Approval for Sale of Gulf Coast Assets
Dow received regulatory approval for a strategic transaction to sell a minority stake in US Gulf Coast infrastructure assets, expecting proceeds of approximately $2.4 billion.
NOVA Litigation Resolution
Dow received a final ruling on the NOVA litigation, expecting to receive more than $1 billion later this year.
Expansion of Alkoxylation Capacity
Dow's new alkoxylation expansion in Cedars, Texas, is expected to be fully operational by mid-2025, targeting key growth markets such as energy and pharmaceuticals.